| |
|
|
JENA, GERMANY - EMD Pharmaceuticals, the U.S. subsidiary of Darmstadt, Germany-based Merck KGaA, will construct a $300-million biomanufacturing plant in Jena, Germany. The 200,000-sf facility will manufacture cancer drugs.
|
|
 |
Would you like information like this delivered to your email inbox? Subscribe to Tradeline Updates to keep abreast of the latest conference developments, industry news, best practices and more! Sign Up Now!
|
|
Printer Friendly Version
Send to a Friend
